DOCSLIB.ORG

DONOR REPORT July 1, 2014 – June 30, 2015 Dear AICF Friends, Board of Directors Scientific the Board of Directors of the American-Italian Daniele D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DONOR REPORT July 1, 2014 – June 30, 2015 Dear AICF Friends, Board of Directors Scientific the Board of Directors of the American-Italian Daniele D AMERICAN-ITALIAN CANCER FOUNDATION DONOR REPORT July 1, 2014 – June 30, 2015 Dear AICF Friends, BOARD OF DIRECTORS SCIENTIFIC The Board of Directors of the American-Italian Daniele D. Bodini, Chairman ADVISORY BOARD: Cancer Foundation (AICF) would like to thank the George M. Pavia, Esq., Secretary EXECUTIVE COMMITTEE generous donors who made gifts and grants to AICF Robert F. Agostinelli Silvia C. Formenti, Chairman in fiscal year 2014-15 in support of cancer research, Gian Andrea Botta Claudio Basilico, MD education and early detection. Alberto Cribiore Riccardo Dalla-Favera, MD The International Post-Doctoral Research Fellowship Claudio Del Vecchio Titia de Lange, PhD Program has effectively launched the scientific careers Massimo Ferragamo Fabrizio Michelassi, MD, FACS of several hundred world-class cancer researchers, many Mario J. Gabelli Larry Norton, MD of whom are among the very best the field has to offer. Philip Olivetti John Petrini, PhD In 2014-15, your generosity supported 16 post-doctoral Joseph R. Perella Virgilio Sacchini, MD research fellowships for outstanding young Italian scientists at Yale University, Columbia University, Memorial Sloan-Kettering, Ottavio Serena di Lapigio MEMBERS Dana Farber Cancer Institute, The University of Texas MD HONORARY MEMBER Joseph R. Bertino, MD Anderson Cancer Center and many others. H.E. Ambassador of Italy Paul A. Bunn, Jr., MD The Mobile, No-cost Breast Cancer Screening Program recruited to the United States, Franco Cavalli, MD and screened more than 4,800 economically disadvantaged New York Claudio Bisogniero Alberto Costa, MD City women in the past year. Many of these women would not have José Costa, MD been screened if we did not reach them where they live, work, and FOUNDERS Vincent T. DeVita, Jr., MD worship. The New York City community has embraced this Program for Alessandro di Montezemolo † Pier Paolo Di Fiore, MD, PhD its relevance in low-income neighborhoods with limited screening access Umberto Veronesi, MD Thomas J. Fahey, Jr., MD and high incidences of breast cancer. EXECUTIVE DIRECTOR Luca Gianni, MD We are delighted that the 2014 Prize for Scientific Excellence in Medicine, Aron Goldhirsch, MD Cristina Aibino sponsored by the Alexander Bodini Foundation, was presented to two John Mendelsohn, MD prominent scientists: James P. Allison, PhD, Chair of Immunology, Division of Franco Muggia, MD Basic Science Research at The University of Texas MD Anderson Cancer Center, Michele Pagano, MD and Jedd Wolchok, MD, PhD, Chief of Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering. Pier Giuseppe Pelicci, MD, PhD Gabriella Sozzi, PhD All of this has been possible because of your great generosity, support and dedication. Andrea Velardi, MD You make a profound difference to AICF and all the people we serve. Roy S. Weiner, MD Deep appreciation also goes to our Board of Directors, the Scientific Advisory Board members, our volunteers, and staff. Thank you, Daniele D. Bodini, Chairman $250,000 & OVER John Lansing Teal Mattia & Beatrice Camerana Bogianchino The Alexander Bodini Foundation $9,999 - $5,000 Francesca Bodini & Zack Sherman $249,999 - $100,000 AGM Partners Amy Bonoff & Harris Jaffe Ed & Eugenia Bayliss The Council of the City of New York Noreen Buckfire Leon & Dedra Black New York State Department Bryna Butler & Tommaso Sandretto of Health Gian Andrea Botta Robert Buxton Amy & Joseph Perella Charitable Fund Council Member Chaim M. Deutsch Vivian Cardia The Forbes Company $99,999 - $50,000 Antonio Carlucci Frank & Elizabeth Ingrassia John K. Castle ACP Group Whitney MacLeod Bryan Cave The Del Vecchio Family Foundation Macy's Inc. Champions for Charity Gabelli Funds Marcum LLP Chandler Construction Company Michael & Valerie Puglisi Memorial Sloan-Kettering James Bass Chanko The National Breast Cancer Center Cancer Foundation Columbia University The Oxford League, Inc. Salvatore Ferragamo USA Cutler, Minikes, & Adelman LLP Council Member Annabel Palma Barbara Daly Ottavio & Charlotte Serena di Lapigio $49,999 - $20,000 Meredith Darrow Sons of Italy Foundation Anna Bulgari Council Member Inez Dickens Sullivan & Cromwell LLP Veronica Bulgari Haimo R. Bradford Evans Ram Sundaram Alberto Cribiore Richard & Francesca Diamond Council Member Paul Vallone Marchesi Antinori William Doyle Weil, Gotshal & Manges LLP Moglia Family Foundation European School of Oncology Welsh, Carson, Anderson & Stowe The Dino Olivetti Foundation Fashion Broker Mark & Giulia Patricelli Weisman William Powers Fera Pharmaceuticals Yum! Brands, Inc RAR Foundation Ferrero USA, Inc. Winston & Strawn LLP $4,999 - $1,000 Charles & Kathleen Foley Bill & Donna Acquavella $19,999 - $10,000 Gianluigi Gabetti ALS Capital, LLC Council Member Daniel Garodnick Robert Agostinelli Aon Foundation Jonathan & Harriet Goldstein Bristol-Myers Squibb Mr. and Mrs. Dan Arbess Goulston & Storrs Natalia Bulgari & Todd Hollander Arthur J. Gallagher & Co. Greenberg Traurig Etro The Barry Friedberg & Chris Henchy Genentech, Inc. Charlotte Moss Foundation Hyland Levin, LLP Council Member Ben Kallos Elisabetta Bartoloni Luca Infantino Mary Minchilli Belkin, Burden, Wenig, & Goldman LLP Allison Klein & Jason Zigelbaum Sandra Atlas Bass and Edythe & Sol G. Atlas Fund Teresa Bitetti Renee Krasny DONORS AICF 2014 Benefit On June 27, 2015, Charmaine M. MOBILE, was the first in line. Dressed in her NO-COST scrubs, she wanted to have her mammogram before she had to be at BREAST work as a home health aid. Despite CANCER working in the health care industry, Charmaine neither had the time nor SCREENING health insurance to regularly receive PROGRAM health care, least of all her annual mammogram, until she learned about the AICF Mobile Care Clinic. AICF’s Mobile, No-cost Breast Cancer Screening Program serves BY THE NUMBERS “I was so excited when I saw the flyer economically-disadvantaged, In fiscal year 2014–2015, last year. I never had a mammogram medically-underserved New York AICF screened 4,829 women — done before and I knew I needed City women, ages 40 and over, who an increase of over 500 women one, but I could never afford it from last year. have not had a mammogram in the because I never had the insurance to last 12 months. The goal of our cover it. I made an appointment with program is to improve the health AICF and had my mammogram. Then outcomes of New York City’s 72% I forgot all about it until you gave me most vulnerable populations: low- had a household income at a call the next year. When I heard you or below $25,000 income, medically-underserved, would be at the First Presbyterian ethnically, linguistically and Church of Jamaica in Queens, even geographically marginalized women 75% closer to me, I decided I had to come by making breast cancer screening identified as women of color again. It is extremely convenient, and and treatment services accessible. the staff is great. I will definitely be AICF’s Mobile Care Clinic travels back next year!” the five boroughs of New York City 42% Our appointment no-show rate has five days a week to provide no-cost spoke a language other dramatically decreased from a high of mammograms, clinical breast exams than English 23% in Fiscal Year 2012/13 to a low and breast health education to those of 10% this year. This decrease is due most in need. We also offer Patient in large part to our commitment to Navigation services to ensure that 38% were uninsured, and 22% program improvement. This year we women with positive results are were underinsured instituted new appointment reminder linked to diagnostic testing and procedures which include phone treatment. 22 calls, emails and text reminders. We AICF makes breast cancer women were diagnosed are now screening more women per screenings accessible to the with breast cancer and are day, increasing our effectiveness and uninsured and underinsured. undergoing treatment ensuring that we are cost efficient. AICF ensures the delivery of appropriate and timely cancer care. Claire, a 63 year old woman, screened with us on July 22, 2014. Claire was out of work and uninsured. Her last mammogram was 5 years ago and she had not gone since then because she was uninsured. When she learned about our no-cost program, she scheduled her appointment. In addition to being no-cost, the screening was close to her home which made it much more affordable and convenient. About a week after her screening, Claire received a call from our Patient Navigator. Claire was informed that she needed diagnostic testing—there was a suspicious lesion in her right breast. Claire was understandably devastated by the results but understood the importance of following through with recommendations. Claire was eventually diagnosed with breast cancer, and by THANK-YOU August 20, two months after her We would like to extend a special thank-you to all of our volunteers & interns: initial screening, she was undergoing Vita Louise Bertolino, Betty Fong, Constance Fontanet, Christina Gignac, Eunaude Guerrier Clermont, treatment. Claire is thankful that our Yoonhee Kim, Mariia Kozina, Timothy Lam, Maria Laterza, Kristina Lippert Kuhn, Claire Marcus, Laura Marengo, Elena Mazzoni, Jason McNeillie, New York Junior League of the City of New York, Elizabeth Rojas, services were available to her and Dawn Rzeznikiewicz, Ann Sullivan, Katty Wu and Ben Wunsch that she was diagnosed early. SCREENING PROGRAM 2014 2015 INTERNATIONAL POST-DOCTORAL RESEARCH FELLOWSHIP PROGRAM The International Post-Doctoral Research GABRIELE DI SANTE, PHD ALESSIA CAVAZZA, PHD Fellowship Program provides financial Gabelli Funds Fellow The Del Vecchio Family Foundation Fellow support for bright Italian scientists who Thomas Jefferson University Dana Farber Cancer Institute pursue post-doctoral research and advanced Mentor: Richard G. Pestell, MBBS, MD, PhD, FRACP Mentor: Ramesh Arjun Shivdasani, MD, PhD training in collaboration with mentors at Being selected as an American-Italian Cancer I decided to join the Dana Farber Cancer major cancer centers in the United States. Foundation Research Fellow has been Institute, an outstanding cancer research center Post-doctoral research fellowships are essential to my career development.
Load more

Recommended publications
  • Investor Presentation, July 2018 Source: Factset As at November 16, 2018; Thomson One; Bloomberg, Q3 Report
    Investor Investor 2018 presentation Investor Day 7th December Eurazeo is ready to grow Virginie Morgon, CEO Agenda 2018 INVESTOR DAY Eurazeo, a large diversified multi-specialist European asset manager p. 8 Solid fundraising capacity ready to grow AuM p. 44 Eurazeo: Idinvest, integrating with Eurazeo p. 54 ready to grow Financial reporting for Eurazeo p. 74 Private debt p. 96 Private funds group p. 112 A deep dive Real assets p. 128 into our asset classes Private equity p. 149 Strong leadership 20+ years in the industry Executive Committee Executive Board Virginie MORGON Marc FRAPPIER PARTNERS CEO Managing Partner – Head of Eurazeo Capital Christophe BAVIERE Benoist GROSSMANN CEO Managing Partner Philippe AUDOUIN Frans TIELEMAN Head of Venture & Growth Directeur Général Managing Partner - Member of the Executive Board Finances - CFO Head of Eurazeo Development Nicolas HUET Renaud HABERKORN General Secretary Managing Partner - Head of Eurazeo Patrimoine Steven LANGMAN Robert AGOSTINELLI Olivier MILLET Caroline HADRBOLEC Co-Founder and Chairman Of the Chief Human Resources Co-Founder and Managing Director Managing Director Executive Board Officer Of Eurazeo PME Eurazeo 2018 Investor Day 4 Our messages Our industry is growing and should continue to do so Our model of balance sheet and third party AuM is uniquely differentiated We are today a large diversified multi-specialist European asset manager Our ambition is global Each of our investment divisions has standalone excellence and ready to grow Eurazeo 2018 Investor Day 5 Global 90+ footprint 380+ 4 230+ investment portfolio asset professionals professionals 9 countries companies classes WE ARE BORN FRENCH OUR SUCCESS IS EUROPEAN OUR AMBITION IS GLOBAL €5bn €17bn €6bn 2x market AuM NAV average CoC capitalisation All partially & fully realised exits since 2002 (…) Nb.
    [Show full text]
  • The Republican Presidential Debate
    2011_04_18 upc_cover61404-postal.qxd 6/14/2011 6:53 PM Page 1 July 4, 2011 49145 $4.99 DANIEL FOSTER on Mamet l ROB LONG on Weiner HowHow toto OutgrowOutgrow $4.99 thethe ObamaObama Years Years 27 Alan Reynolds l Kevin A. Hassett l Chris Chocola l Reihan Salam Veronique de Rugy l Keith Hennessey l David Beckworth l Jim Manzi Samuel Gregg l Kevin D. Williamson 0 74820 08155 6 www.nationalreview.com base_milliken-mar 22.qxd 6/13/2011 11:32 AM Page 1 “ The commitment to safety among nuclear plant operators is second to none.” ÊÊ Douglas Cobb, Shift Manager-Operations at the Surry nuclear energy facility in Virginia. ÊÊÊÊÊÊÊÊÊÊÊÊÊ ommunities have the right to know the safety record Plant operators undergo intensive training and are frequently of their nuclear energy plants. We are proud to tested on simulators that are exact replicas of their plant C share it. Professionals like Doug Cobb work every control rooms. They are held to the highest of standards by day to exceed already stringent federal safety standards at independent Nuclear Regulatory Commission inspectors who America’s nuclear power plants provide ongoing oversight at every reactor every day. American nuclear plants are among the safest in the world American energy companies are the world leaders in nuclear because they are managed and operated by leading engineers, energy, with 104 reactors producing one-fifth of our electricity. scientists and licensed reactor operators. They undergo Providing affordable electricity and ending our dependence significantly more oversight and have more safety measures on foreign energy sources simply cannot be achieved in place than reactors in other countries.
    [Show full text]
  • The Henry Jackson Society and the Degeneration of British
    Tom Griffin Hilary Aked David Miller Sarah Marusek THE HENRY JACKSON SOCIETY AND THE DEGENERATION JUNE 2015 OF BRITISH NEOCONSERVATISM: LIBERAL INTERVENTIONISM, ISLAMOPHOBIA AND THE ‘WAR ON TERROR’ Sponsored by: ISBN 978-0-9570274-4-2 AUTHOR PROFILES David Miller is Professor of Sociology in the Department of Social and Policy Sciences at the University of Bath. He is an RCUK Global Uncertainties Leader- ship Fellow (2013-15) conducting Tom Griffin is a freelance writer and a project to examine the construc- researcher and a doctoral candidate tion, use and impact of expertise on at the University of Bath. He is a ‘terrorism’. He has written widely on contributing editor of OpenDemoc- propaganda, spin and lobbying and racy’s OurKingdom blog and writes for was co-founder of Public Interest Investigations a non profit Spinwatch. He is a former executive company of which Spinwatch and Powerbase are projects. editor and political correspondent of Recent publications include: A Century of Spin: How Public the Irish World. Relations Became the Cutting Edge of Corporate Power (Pluto Press, 2008, co-author); Neoliberal Scotland (Cam- bridge Scholars, 2010, co-editor); Critical Terrorism Studies Dr Sarah Marusek is a freelance since 11 September 2001. What has been learned? (Rout- researcher and writer. She has a PhD in ledge, 2014, co-editor). Researching the Powerful: Public social science from the Maxwell School Sociology in Action (Routledge, forthcoming, co-editor). of Syracuse University. Her doctoral research focused on Islamic activism in Lebanon and was funded by the gener- Hilary Aked is a freelance researcher ous support of the Mellon Foundation.
    [Show full text]
  • 2018 Registration Document
    2018 Registration document Annual Financial Report CONTENTS Group overview 3 Company financial statements 297 1 The strength of a unique model 20 5 5.1 Balance Sheet 298 A multi-expertise strategy 26 5.2 Income Statement 300 Scope of a global group 38 5.3 Notes to the Company financial statements 301 5.4 Statutory Auditors’ report on the financial statements 327 Eurazeo’s Corporate Social 5.5 Five-year financial summary (Article R. 225-102 of the French Commercial Code) 330 Responsibility 77 5.6 Customer and supplier settlement periods 331 2 2.1 A proactive CSR strategy 78 2.2 Non-Financial Performance Statement 92 Information on the Company 2.3 Methodology 117 and the share capital 333 2.4 Statutory Auditors’ reports 120 6 6.1 Information on the Company – Bylaws 334 6.2 Information on the share capital 340 6.3 Shareholding structure 344 Governance 125 6.4 Shareholders’ agreements 348 3 3.1 Management and Supervisory Bodies 126 6.5 Transactions in the Company’s shares 351 3.2 Compensation and other benefits received 6.6 Factors affecting a potential takeover bid 354 by corporate officers 165 6.7 Additional information 357 3.3 Interests held by members of the Supervisory and Executive Boards in the Company’s share capital and transactions in the Company’s shares by members of the Supervisory and Executive Boards 187 3.4 Risk management, internal control and main risk factors 189 Shareholders’ Meeting 361 3.5 Commitments under co-investment plans 204 7 7.1 Special Report on share subscription and purchase options (Article L.
    [Show full text]
  • Printmgr File
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act File Number 811-05823 DOMINI INVESTMENT TRUST (Exact Name of Registrant as Specified in Charter) 180 Maiden Lane, Ste. 1302, New York, New York 10038 (Address of Principal Executive Offices) Carole M. Laible Domini Impact Investments LLC 180 Maiden Lane, Ste. 1302 New York, New York 10038 (Name and Address of Agent for Service) Registrant’s Telephone Number, including Area Code: 212-217-1100 Date of Fiscal Year End: July 31 Date of Reporting Period: June 30, 2018 Item 1. Proxy Voting Record. Information for each matter relating to a portfolio security considered at any shareholder meeting held from July 1, 2017, through June 30, 2018 with respect to which the Domini Impact Equity Fund and Domini Impact International Equity Fund were entitled to vote follows. The Domini Impact Bond Fund did not hold any voting securities during the period covered by the report, and, therefore, has no proxy votes to report. <PAGE> ******************************* FORM N-Px REPORT ******************************* ICA File Number: 811-05823 Reporting Period: 07/01/2017 - 06/30/2018 Domini Investment Trust ========================== Domini Impact Equity Fund =========================== 3M COMPANY Ticker: MMM Security ID: 88579Y101 Meeting Date: MAY 08, 2018 Meeting Type: Annual Record Date: MAR 13, 2018 # Proposal Mgt Rec Vote Cast Sponsor 1a Elect Director Sondra L. Barbour For For Management 1b Elect Director Thomas ’Tony’ K. Brown For For Management 1c Elect Director David B. Dillon For For Management 1d Elect Director Michael L.
    [Show full text]
  • Combined Shareholders' Meeting of April 25, 2018
    COMBINED SHAREHOLDERS’ MEETING OF APRIL 25, 2018 Paris, April 25, 2018 - Eurazeo’s Combined Shareholders’ Meeting was held today in Paris. All forty- three resolutions presented were approved. This Shareholders’ Meeting closes a year of major transformations for Eurazeo: • Change in share ownership with the Decaux family’s investment in Eurazeo; • Change in governance with the appointment of a new Executive Board, chaired by Virginie Morgon, and an expanded Executive Committee; • Acquisition of a 70% stake in Idinvest, a leader in venture & growth capital, private debt and dedicated portfolios & funds in France and Europe; • Strategic partnership with Rhône, a major market and transatlantic player; • Birth of a new investment division, Eurazeo Brands, dedicated to high-potential brands. Activity was also brisk over these last twelve months, with the acquisition of nine new companies and partial or total divestments of eight companies. The 2018 Shareholders’ Meeting thus coincides with a key moment in Eurazeo’s development. The goal is to become a leading partner to entrepreneurs and management teams, by bolstering our presence in all segments of business financing and driving their transformation. The proposed dividend of €1.25 per share was approved by the Shareholders’ Meeting. It will be paid on May 3, 2018. The Shareholders’ Meeting also approved the appointment of Mr. Patrick Sayer, former CEO of Eurazeo and Mrs. Oudéa-Castera, former Chief Marketing & Digital Officer of Axa, as members of the Supervisory Board. Mr. Robert Agostinelli, Co-Founder and Managing Director of Rhône, was appointed as a non- voting member. *** About Eurazeo > With a diversified portfolio of approximately €15 billion in assets under management1, including €9 billion from third parties, Eurazeo is a leading global investment company with offices in Paris and Luxembourg, New York, Shanghai and Sao Paulo.
    [Show full text]
  • Report from the Executive Board and Resolutions Submitted To
    AGENDA Audouin, following the renewal of his term of office as a member of the Executive Board. 26. Approval of agreements and commitments governed by Resolutions before the Ordinary Articles L. 225-86 and L. 225-90-1 of the French Commercial Code Shareholders’ Meeting and the Statutory Auditors’ Special Report, concerning Nicolas Huet, following his appointment as a member of the Executive 1. Approval of the Company financial statements for the year ended Board. December 31, 2017. 27. Approval of agreements and commitments governed by 2. Allocation of net income for the year and dividend distribution. Articles L. 225-86 and L. 225-90-1 of the French Commercial Code 3. Approval of the consolidated financial statements for the year and the Statutory Auditors’ Special Report, concerning Olivier ended December 31, 2017. Millet, following his appointment as a member of the Executive 4. Approval of agreements and commitments governed by Board. Article L. 225-86 of the French Commercial Code. 28. Setting of the total annual amount of attendance fees. 5. Approval of agreements governed by Article L. 225-86 of the 29. Authorization of a share buyback program by the Company for its French Commercial Code between the Company and JCDecaux own shares. Holding SAS. 6. Approval of an agreement governed by Article L. 225-86 of the French Commercial Code between the Company and certain Resolutions before the Extraordinary shareholders of the Company that are members of the Concert Shareholders’ Meeting (2010 Agreement). 30. Delegation of authority to the Executive Board to increase share 7. Ratification of the appointment of Jean-Charles Decaux as a capital by capitalizing reserves, profits or share, merger or member of the Supervisory Board.
    [Show full text]
  • 2017 REGISTRATION DOCUMENT Annual Financial Report Worldreginfo - E145910a-Ed67-4E1c-A0cc-D843bdee007e CONTENTS
    2017 REGISTRATION DOCUMENT Annual Financial Report WorldReginfo - e145910a-ed67-4e1c-a0cc-d843bdee007e CONTENTS Presentation of the group 3 Company financial statements 283 1.1 Chairman's Message and joint interview 4 5 5.1 Balance Sheet 284 1.2 Made by US 14 5.2 Income Statement 286 1.3 Made with YOU 28 5.3 Notes to the Company financial statements 287 1.4 Made for ALL 60 5.4 Statutory Auditors' report on the financial statements 313 1.5 Other Management Report information 83 5.5 Five-year financial summary (Article R. 225-102 of the 316 French Commercial Code) 5.6 Customer and supplier settlement periods 317 Eurazeo’s corporate social 89 responsibility 2 Information on the Company and 319 2.1 CSR in the investment policy 90 the share capital 2.2 Progress and highlights of the year 96 6 6.1 Information on the Company – Bylaws 320 2.3 Social information 106 6.2 Information on the share capital 326 2.4 Environmental information 112 6.3 Shareholding structure 330 2.5 Societal information 120 6.4 Shareholders’ agreements 334 2.6 Methodology 125 6.5 Transactions in the Company’s shares 336 2.7 Report of one of the Statutory Auditors, designated 127 as independent third-party, on the consolidated 6.6 Factors affecting a potential takeover bid 339 social, environmental and societal information 6.7 Additional information 341 presented in the Management Report Governance 131 Shareholders’ Meetings 345 7.1 Special Report on share subscription and purchase 346 3.1 Management and Supervisory Bodies 132 7 3 options (Article L.
    [Show full text]
  • Israel’ 14 European Friends of Israel
    British Cataloguing-in-Publications Data. Further information A catalogue record for this report is available from Website: www.spinwatch.org the British Library. Email: [email protected] Mail: Spinwatch, Box 1, c/o Govanhill Baths ISBN 978-0-9570274-7-3 Community Trust 99 Calder Street, Glasgow G42 7RA Copyrights Public Interest Investigations © 2016. All rights reserved. No part of this publication maybe reproduced, stored or transmitted in any form of by any means without the prior permission from the copyright holder. Disclaimer Views and opinions expressed in this publication are those of the individual contributors and do Public Interest Investigations is an not necessarily reflect those of Public Interest independent non-profit making organisation. Investigations. Founded in 2004, Public Interest Investigations promotes greater understanding of the role Order copies of PR, propaganda, lobbying and of the This report is available for download free of charge power networks that they support, through via: www.spinwatch.org | www.europalforum.org.uk its website Spinwatch (spinwatch.org) and its investigative wiki site Powerbase (powerbase. Acknowledgements info). This report is based on research by a variety of Public Interest Investigations researchers and by the authors. The authors would like to acknowledge the following people who have advised and helped in the production of this report. We thank colleagues at Spinwatch including Tamasin Cave, Will Dinan, Eveline Lubbers and Andy Rowell, but especially Melissa Jones for editorial assistance. For research, advice and other help, Hilary Aked, Alex Doherty, James Gallagher, Tom Griffin, Josh Leeson, Narzanin Massoumi, Tom Mills, Jamie Stern-Weiner and Charlotte Young.
    [Show full text]
  • Eurazeo’S Corporate Social 5.5 Five-Year Financial Summary (Article R
    2018 Registration document Annual Financial Report CONTENTS Group overview 3 Company financial statements 297 1 The strength of a unique model 20 5 5.1 Balance Sheet 298 A multi-expertise strategy 26 5.2 Income Statement 300 Scope of a global group 38 5.3 Notes to the Company financial statements 301 5.4 Statutory Auditors’ report on the financial statements 327 Eurazeo’s Corporate Social 5.5 Five-year financial summary (Article R. 225-102 of the French Commercial Code) 330 Responsibility 77 5.6 Customer and supplier settlement periods 331 2 2.1 A proactive CSR strategy 78 2.2 Non-Financial Performance Statement 92 Information on the Company 2.3 Methodology 117 and the share capital 333 2.4 Statutory Auditors’ reports 120 6 6.1 Information on the Company – Bylaws 334 6.2 Information on the share capital 340 6.3 Shareholding structure 344 Governance 125 6.4 Shareholders’ agreements 348 3 3.1 Management and Supervisory Bodies 126 6.5 Transactions in the Company’s shares 351 3.2 Compensation and other benefits received 6.6 Factors affecting a potential takeover bid 354 by corporate officers 165 6.7 Additional information 357 3.3 Interests held by members of the Supervisory and Executive Boards in the Company’s share capital and transactions in the Company’s shares by members of the Supervisory and Executive Boards 187 3.4 Risk management, internal control and main risk factors 189 Shareholders’ Meeting 361 3.5 Commitments under co-investment plans 204 7 7.1 Special Report on share subscription and purchase options (Article L.
    [Show full text]
  • Eurazeo and Rhône to Form Strategic Partnership
    EURAZEO AND RHÔNE TO FORM STRATEGIC PARTNERSHIP EURAZEO TO ACQUIRE A MINORITY STRATEGIC INTEREST IN RHÔNE RHÔNE PARTNERS BECOME EURAZEO SHAREHOLDERS PARTNERSHIP WILL ACCELERATE THE LONG-TERM STRATEGIC DEVELOPMENT OF BOTH FIRMS Paris, London & New York, November 29, 2017 -- Eurazeo, a leading global listed investment company based in Paris and New York, and Rhône, a leading international private equity firm based in New York and London, today announce a strategic partnership. Under the terms of the agreement, Eurazeo will acquire a 30% interest in Rhône in exchange for $100 million cash (€84 million) and 2 million newly issued Eurazeo shares. Eurazeo is a Euronext-listed investment company, with total assets under management of €7 billion. Rhône is a global alternative investment management firm with over €5 billion in assets under management across both its private equity business and its real estate joint venture with WeWork, the global leader in the collaborative workspace industry. The partnership is predicated on both firms’ like-minded investment philosophy, common and complementary transatlantic heritage, and historical cultural alignment. This is evidenced by the global geographical presence of each firm, anchored by their common European and American heritage and long-standing network of relationships. The complementary skills and character of each firm will serve to enhance the benefits of the partnership for both firms and their stakeholders, including broadening their scale and scope of investment capabilities and reinforcing and cross-pollinating respective networks. One Rhône representative will serve as an observer on the Eurazeo Supervisory Board while three Eurazeo representatives will serve on Rhône’s Board of Managers.
    [Show full text]
  • THE NEW MELTING POT by Reihan Salam Bombast and Chauvinism Must Not Prevent Compassionate Assimilation
    20151231upc_cover61404-postal.qxd 12/15/2015 9:05 PM Page 1 December 31, 2015 $4.99 Christmas!Merry CHARLES C. W. COOKE: RAMESH PONNURU: WHY SELF-DEFENSE MATTERS CRUZVS. RUBIO YES,YES, RETHINK IMMIGRATION The case for a new melting-pot nationalism REIHAN SALAM www.nationalreview.com base_milliken-mar 22.qxd 12/14/2015 12:37 PM Page 1 TOC_QXP-1127940144.qxp 12/16/2015 2:22 PM Page 1 Contents DECEMBER 31, 2015 | VOLUME LXVII, NO. 24 | www.nationalreview.com ON THE COVER Page 22 The New Melting Pot Jay Nordlinger on Clive A. Babkirk A new culture war is breaking p. 40 out over the future of American national identity in the face of rapid and accelerating demographic change. BOOKS, ARTS To win this new culture war, conserva- & MANNERS tives must do more than embrace a 35 THE REDUCTIONIST TRAP new approach to immigration. They Daniel Foster reviews The Evolution of Everything: must offer a new conception of How New Ideas Emerge, by Matt Ridley. American nationhood. Reihan Salam 37 A NEW CHRISTIAN COVER: ROMAN GENN Sarah Ruden reviews Augustine: Conversions to Confessions, by Robin Lane Fox. ARTICLES 38 MYSTERY MAN 15 CRUZ VS. RUBIO by Ramesh Ponnuru Robert Dean Lurie reviews They are having to disagree because they are so much alike. The Political World of Bob Dylan: Freedom and Justice, 16 DISCRIMINATING DISCRIMINATION by Kevin D. Williamson Power and Sin, by Jeff Taylor and Of Donald Trump and immigration. Chad Israelson. RECLAIMING TRADITIONAL EDUCATION by Samuel Goldman 18 40 AN AMERICAN ORIGINAL Why we should study old books and beautiful things.
    [Show full text]